股票/基金 实时行情 股吧

简称:浙江医药 代码:600216


会计年度:2020-06-30收入分布
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合计3,528,496,835.732,115,491,395.011,413,005,440.7240.05
其他2,781,487.192,931,509.24-150,022.05-5.39
其他(补充)11,171,438.4816,386,790.50-5,215,352.02-46.68
生命营养品1,637,140,548.01950,325,924.03686,814,623.9841.95
医药商业类908,557,151.72860,358,393.0148,198,758.715.30
医药制造类968,846,210.33285,488,778.23683,357,432.1070.53

会计年度:2019-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
其他4,779,260.913,509,577.211,269,683.7026.57
生命营养品2,283,944,021.151,517,925,580.67766,018,440.4833.54
医药商业类2,233,868,174.792,091,533,970.18142,334,204.616.37
医药制造类2,500,747,266.23539,686,763.041,961,060,503.1978.42
总计7,023,338,723.084,152,655,891.102,870,682,831.9840.87

会计年度:2018-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
其他8,311,331.498,517,971.77-206,640.28-2.49
生命营养品2,670,347,414.681,622,867,888.971,047,479,525.7139.23
医药商业类1,858,871,211.391,762,128,205.6296,743,005.775.20
医药制造类2,302,144,135.91582,435,039.571,719,709,096.3474.70
总计6,839,674,093.473,975,949,105.932,863,724,987.5441.87

会计年度:2017-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
其他15,082,690.559,554,717.825,527,972.7336.65
生命营养品2,440,687,277.041,748,430,881.37692,256,395.6728.36
医药商业类1,870,153,212.371,765,529,136.73104,624,075.645.59
医药制造类1,354,218,709.94473,686,480.74880,532,229.2065.02
总计5,680,141,889.903,997,201,216.661,682,940,673.2429.63

会计年度:2017-06-30 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
其他737.82509.53228.2930.94
生命营养品102,827.1778,113.2124,713.9624.03
医药商业类95,178.3490,430.644,747.704.99
医药制造类49,374.5620,568.1128,806.4558.34

    1/8 转到